Angeion Considering Sale Of Company Among Options To Raise Capital
This article was originally published in The Gray Sheet
Executive Summary
Strategic alternatives under consideration by implantable defibrillator maker Angeion include a merger or outright sale of the company, as well as partnerships with other firms, equity investments and debt offerings.